The pandemic has created a slowdown in inspections, particularly with inspections of sites outside the U.S. The FDA has recently resumed “normal operations” with respect to inspections but sites that are not deemed mission-critical by the FDA may still find themselves stuck in a long queue, waiting for an inspection. This session will focus on how to communicate with the FDA regarding when your site might expect an inspection and in what circumstances you can provide information (and what information you can provide) that might make that inspection happen sooner rather than later.